Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 May 30;14(5):2544-2547.
doi: 10.21037/tcr-2024-2615. Epub 2025 May 19.

"Prime and pull" vaccination strategy for treatment of cervical pre-cancer: not quite ready for prime time

Affiliations
Editorial

"Prime and pull" vaccination strategy for treatment of cervical pre-cancer: not quite ready for prime time

Katherine Cooke et al. Transl Cancer Res. .
No abstract available

Keywords: Cervical intraepithelial neoplasia (CIN); cervical cancer prevention; human papillomavirus vaccination (HPV vaccination); imiquimod.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-2024-2615/coif). D.G.K.T. has research funding from the US Department of Defense, Jounce Therapeutics, Moderna, and Glaxo Smith Kline. The other author has no conflicts of interest to declare.

Comment on

References

    1. Liu R, Liu C, Ding X. Association between loop electrosurgical excision procedure and adverse pregnancy outcomes: a meta-analysis. J Matern Fetal Neonatal Med 2023;36:2183769. 10.1080/14767058.2023.2183769 - DOI - PubMed
    1. Sheth SS, Oh JE, Bellone S, et al. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147). Clin Cancer Res 2024;30:1768-77. 10.1158/1078-0432.CCR-23-3639 - DOI - PubMed
    1. Hendriks N, Koeneman MM, van de Sande AJM, et al. Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study. J Immunother 2022;45:180-6. 10.1097/CJI.0000000000000414 - DOI - PMC - PubMed
    1. Cokan A, Pakiž M, Serdinšek T, et al. Comparison of Conservative Treatment of Cervical Intraepithelial Lesions with Imiquimod with Standard Excisional Technique Using LLETZ: A Randomized Controlled Trial. J Clin Med 2021;10:5777. 10.3390/jcm10245777 - DOI - PMC - PubMed
    1. Fonseca BO, Possati-Resende JC, Salcedo MP, et al. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial. Obstet Gynecol 2021;137:1043-53. 10.1097/AOG.0000000000004384 - DOI - PMC - PubMed